214 related articles for article (PubMed ID: 12145737)
1. Infection due to non-Aspergillus fungi in immunocompromised patients receiving itraconazole.
Myoken Y; Sugata T; Mikami Y
Clin Infect Dis; 2002 Aug; 35(4):494-5; author reply 495. PubMed ID: 12145737
[No Abstract] [Full Text] [Related]
2. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
Barbaric D; Shaw PJ
Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
[TBL] [Abstract][Full Text] [Related]
3. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia.
Ng KP; Soo-Hoo TS; Na SL; Gan GG; Sangkar JV; Teh AK
Med J Malaysia; 2003 Oct; 58(4):608-12. PubMed ID: 15190640
[TBL] [Abstract][Full Text] [Related]
4. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
Perfect JR
Clin Infect Dis; 2005 May; 40 Suppl 6():S401-8. PubMed ID: 15809926
[TBL] [Abstract][Full Text] [Related]
5. [Severe viral hepatitis complicated with pleural aspergillus infection treated with itraconazole and amphotericin B].
Wang HF; Su HB; Li HW; Jin B; Chen J; Zhang AM
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):690-1. PubMed ID: 16995989
[No Abstract] [Full Text] [Related]
6. [Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
Wang JZ; Huang XJ; Liu KY; Liu DH; Chen H; Xu LP; Lu J; Zhang YC; Han W; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1481-3. PubMed ID: 16061027
[TBL] [Abstract][Full Text] [Related]
7. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
[TBL] [Abstract][Full Text] [Related]
8. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
9. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B found safe and effective.
AIDS Patient Care STDS; 1998 Jan; 12(1):69. PubMed ID: 11361899
[No Abstract] [Full Text] [Related]
11. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
12. Systemic antifungal drugs.
Med Lett Drugs Ther; 1994 Feb; 36(916):16-8. PubMed ID: 8302208
[No Abstract] [Full Text] [Related]
13. Cerebral aspergillosis caused by Neosartorya hiratsukae, Brazil.
Guarro J; Kallas EG; Godoy P; Karenina A; Gené J; Stchigel A; Colombo AL
Emerg Infect Dis; 2002 Sep; 8(9):989-91. PubMed ID: 12194781
[TBL] [Abstract][Full Text] [Related]
14. [Invasive aspergillosis in immunocompromised patients].
Kliasova GA; Petrova NA; Galstian GM; Gotman LN; Vishnevskaia ES; Sysoeva EP; Khoroshko ND; Mikhaĭlova EA; Parovichnikova EN; Isaev VG
Ter Arkh; 2003; 75(7):63-8. PubMed ID: 12934484
[TBL] [Abstract][Full Text] [Related]
15. [Systemic antifungal drugs].
Kujala P; Ruutu P
Duodecim; 1991; 107(10):767-76. PubMed ID: 1364720
[No Abstract] [Full Text] [Related]
16. Systemic antifungal drugs.
Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
[No Abstract] [Full Text] [Related]
17. Simultaneous determination of itraconazole, hydroxy-itraconazole and amphotericin B in human plasma by HPLC with photodiode array detection.
Lacroix C; Wojciechowski F; Danger P
Ann Biol Clin (Paris); 1995; 53(5):293-7. PubMed ID: 7574117
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole: managing mycotic complications in immunocompromised patients.
Graybill JR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):58-63. PubMed ID: 9671333
[TBL] [Abstract][Full Text] [Related]
19. Treatment of invasive fungal infections.
Warnock DW
Hosp Med; 1998 Apr; 59(4):266-7. PubMed ID: 9722362
[No Abstract] [Full Text] [Related]
20. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
Agarwal PK; Roy P; Das A; Banerjee A; Maity PK; Banerjee AR
Indian J Ophthalmol; 2001 Sep; 49(3):173-6. PubMed ID: 15887725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
